Industry Corner Live With Synchron CEO Tom Oxley.

IF 1.2 4区医学 Q4 ENGINEERING, BIOMEDICAL

IEEE Pulse Pub Date : 2025-05-01 DOI:10.1109/MPULS.2025.3572578

Chad Anderson

{"title":"Industry Corner Live With Synchron CEO Tom Oxley.","authors":"Chad Anderson","doi":"10.1109/MPULS.2025.3572578","DOIUrl":null,"url":null,"abstract":"<p><p>Pulse's Industry Corner Live featured a dynamic live Q&A session between IEEE Pulse Editor-in-Chief Chad Andresen and Dr. Tom Oxley, CEO and co-founder of Synchron, a leader in minimally invasive brain-computer interface (BCI) technology. The discussion explored the intersection of neurotechnology, artificial intelligence, and the evolving landscape of entrepreneurship in the MedTech sector. Dr. Oxley shared insights into Synchron's pioneering work with endovascular BCIs, offering a less invasive alternative to traditional neurosurgical approaches, and how this technology is reshaping the possibilities for restoring communication in patients with paralysis. The conversation delved into the growing role of AI in decoding neural signals and driving clinical translation, while also addressing the regulatory, financial, and ethical challenges faced by entrepreneurs in the neurotechnology space. With candid reflections on his journey from clinician to startup founder, Oxley provided an inside look at what it takes to bring disruptive technologies from concept to clinic. This session offered a rare glimpse into the mindset of a neurotech innovator navigating the high-stakes interface of science, medicine, and industry.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 3","pages":"43-49"},"PeriodicalIF":1.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Pulse","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1109/MPULS.2025.3572578","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Pulse's Industry Corner Live featured a dynamic live Q&A session between IEEE Pulse Editor-in-Chief Chad Andresen and Dr. Tom Oxley, CEO and co-founder of Synchron, a leader in minimally invasive brain-computer interface (BCI) technology. The discussion explored the intersection of neurotechnology, artificial intelligence, and the evolving landscape of entrepreneurship in the MedTech sector. Dr. Oxley shared insights into Synchron's pioneering work with endovascular BCIs, offering a less invasive alternative to traditional neurosurgical approaches, and how this technology is reshaping the possibilities for restoring communication in patients with paralysis. The conversation delved into the growing role of AI in decoding neural signals and driving clinical translation, while also addressing the regulatory, financial, and ethical challenges faced by entrepreneurs in the neurotechnology space. With candid reflections on his journey from clinician to startup founder, Oxley provided an inside look at what it takes to bring disruptive technologies from concept to clinic. This session offered a rare glimpse into the mindset of a neurotech innovator navigating the high-stakes interface of science, medicine, and industry.

查看原文本刊更多论文

行业之角与同步的首席执行官汤姆·奥克斯利。

《脉冲》的行业角直播在IEEE Pulse总编辑Chad Andresen和微创脑机接口（BCI）技术领导者Synchron的首席执行官兼联合创始人Tom Oxley博士之间进行了动态的现场问答。讨论探讨了神经技术、人工智能的交叉，以及医疗技术领域不断发展的创业前景。奥克斯利博士分享了Synchron在血管内脑机接口方面的开创性工作，为传统的神经外科方法提供了一种侵入性更小的替代方案，以及这项技术如何重塑瘫痪患者恢复沟通的可能性。对话深入探讨了人工智能在解码神经信号和推动临床翻译方面日益重要的作用，同时也解决了神经技术领域企业家面临的监管、财务和道德挑战。奥克斯利坦诚地回顾了自己从临床医生到创业公司创始人的历程，并深入了解了颠覆性技术从概念到临床的过程。这次会议提供了一个难得的机会，让我们得以一窥神经技术创新者在科学、医学和工业的高风险界面中导航的心态。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

IEEE Pulse ENGINEERING, BIOMEDICAL-

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.